Cyclerion Therapeutics

North America Legal Chronicle. April 3, 2026

Korsana Biosciences and Cyclerion Therapeutics Announce All-Stock Merger and $380 Million Financing

By Leila Ahmed

Gibson Dunn has advised Korsana Biosciences. Ropes & Gray has advised Cyclerion Therapeutics. Korsana Biosciences and Cyclerion Therapeutics, Inc. have entered into a definitive agreement to...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

North America Legal Chronicle. June 16, 2023

Cyclerion Therapeutics’ Sale of Medicine to Treat Mitochondrial Encephalopathy

By Laura Testa

Hughes Hubbard & Reed LLP represented Cyclerion Therapeutics in the deal. Cyclerion Therapeutics (NASDAQ: CYCN) announced the company’s sale of the rights to two drugs used...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

North America. North America Legal Chronicle. June 21, 2021

Cyclerion Therapeutics’ Licensing Agreement With Akebia Therapeutics

By Martina Bellini

Morgan Lewis represented Cyclerion Therapeutics in the transaction. Cyclerion Therapeutics Inc. closed a licensing agreement with Akebia Therapeutics Inc. for the development and commercialization of praliciguat,...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Beep Closes its Series B Funding to Expand Autonomous Mobility Solutions

Alif Semiconductor to Be Acquired by Analog Devices in US$1.35 Billion Deal

TwoStep Therapeutics Secures US$62.5 Million Series A Financing and IND Clearance for TS-104

YPF Issues USD 1.2 Billion Notes and Completes Cash Tender Offers

Pluma Agroavícola Participates in BRL 160 Million Agribusiness Financing through FIDC and FIAGRO Structures

Mirgor’s Issuance of Additional Class VI and Class VII Notes

The Exploration Company Raises $450 Million in Series C Financing for Space Expansion

PKO Bank Polski Issues €500 Million Senior Non-Preferred Green Notes

Orgvue Acquired by Main Capital Partners

Solar Group Proposes ZAR21.8 Billion Acquisition of Omnia Holdings

Al Baraka Bank Egypt Launches Share Swap Offer for AT Lease

Genser Energy Secures EUR456 Million Syndicated Facilities for West African Expansion

Development Bank of Kazakhstan Completes Landmark RMB 3.7 Billion Dim Sum Bond Offering

E Point Zero Acquires Azura Power Holdings Limited

$100 Million Trade Finance Facility Agreement Reached Between BADEA and The Gambia Government

Copenhagen Infrastructure Partners Acquires and Secures Project Financing for Gawara Baya Hybrid Project

RBL Bank Establishes US$1bn Euro Medium Term Note Programme and Completes Inaugural US$350m Issuance

Bharat Forge Completes ?2,000 Crore Qualified Institutions Placement

Pachulski Stang Ziehl & Jones Elects Bradford Sandler as the Firm’s First Chair

Lowenstein Sandler Names Marie T. DeFalco and Sara R. Werner Co-chairs of Venture Funds Launch Group

Finn Dixon & Herling Names Claire Stevens as Chair of Investment Management Practice

Mayer Brown expands premier finance platform with addition of leveraged finance and private credit partner Kerrick Seay in New York

O’Melveny Expands Bankruptcy & Restructuring Team with Leading Corporate Restructuring Lawyer Penelope Jensen

Milbank Strengthens Tax Practice with the Addition of Leading Tax Lawyer Alex Anderson

Korsana Biosciences and Cyclerion Therapeutics Announce All-Stock Merger and $380 Million Financing

Membership Required

Cyclerion Therapeutics’ Sale of Medicine to Treat Mitochondrial Encephalopathy

Membership Required

Cyclerion Therapeutics’ Licensing Agreement With Akebia Therapeutics

Membership Required